FDA NDC Directory · JSON-LD · Markdown

Talzenna

NDC 0069-1501 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nametalazoparib
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryNew Drug Application (innovator) · App NDA211651
Dosage form / routeCAPSULE · ORAL
Active ingredientsTALAZOPARIB TOSYLATE (.5 mg/1)
Marketing started20220131
Marketing ended20270331
Package count1

External sources

Source: openFDA. Public-domain (CC0).